News
The Vallabh/Minikel lab at the Broad Institute has selected Argonaut Manufacturing Services, Inc., "Argonaut," as the drug ...
In a notable milestone, Boson Quantum in 2024 sold China's first commercial photonic quantum computer and issued the first ...
MessageGears, the leading data activation and engagement platform for enterprise brands, today announced it has been recognized as a Validated Partner of Databricks, the data and AI company. The ...
PlayerWON is excited to announce the official launch of its Unreal Software Development Kit (SDK) on the FAB Store. This new SDK is designed to provide Unreal Engine game developers with a powerful ...
Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2025 investor letter. A ...
President Donald J. Trump issued Executive Order (“EO”) 14293 entitled Regulatory Relief to Promote Domestic Production of ...
Ultrapar Participações S.A. ( NYSE: UGP) Q1 2025 Earnings Conference Call May 8, 2025 10:00 AM ET Rodrigo Pizzinatto - Chief Executive Officer Alexandre Palhares - Chief Financial and Investor ...
2d
Health and Me on MSNWith Flu On The Rise And COVID Still Lurking, Can You Get Your New Vaccinations Together?With flu cases climbing and new COVID-19 variants like JN.1 circulating, experts urge timely vaccination. Getting both flu ...
Breakthroughs in science tend to start with a small step. For scientists in Australia, a small step might offer new hope to patients who are suffering from neurodegenerative diseases such as ...
ONEOK’s acquisitions strengthen its midstream network and cash flows, but integration risks and valuation limit upside. Find ...
GSK said it is ending the development program for the small-molecule drug Belrestotug. The British pharmaceutical giant said Tuesday that the decision is based on a new interim analyses from phase ...
Lars Fruergaard Jørgensen will step down from his role as CEO of Novo Nordisk. In the meantime, a search for Jørgensen’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results